Letters to the Editor
ONS Publishing Division Policy Regarding Letters to the Editor: Selection of letters to be published in Letters to the Editor is the decision of the editor. For acceptance, letters must be signed. A letter can appear anonymously if requested by the author. All letters are subject to editing.
A letter that questions, criticizes, or responds to a previously published Clinical Journal of Oncology Nursing article automatically will be sent to the author of that article for a reply. This type of collegial exchange is encouraged. Letters that question, criticize, or respond to an Oncology Nursing Society (ONS) policy, product, or activity will appear in ONS Connect and automatically will be sent to the ONS Board of Directors for a reply. Send letters to CJONEditor@ons.org.
Debruyne, F. (2002). Hormonal therapy of prostate cancer. <i>Seminars in Urologic Oncology</i>, 20(3, Suppl. 1), 4-9.
Tan, S. G., & Wolff, A. C. (2007). Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cacner. <i>Clinical Breast Cancer</i>, 7(6), 455-464.